However, PKM2 also phosphorylates non-metabolic substrates, for example stabilizing Bcl-2 [75] and influencing transcription via phosphorylation of histone 3, already demonstrated in neuroblastoma [76], and perturbation of these pathways may contribute to GSK3203591-mediated growth inhibition. The gene discussed is PKM; the disease is neuroblastoma.